CDC surveillance shows ER visits for tick bites at their highest level in nearly a decade. Nashville clinicians warn warm, dry weather could mean more bites and infections.

New research warns that prenatal, postpartum and mental‑health programs are shrinking in Tampa and Florida, with Black mothers at greatest risk.

Macomb County confirmed its first measles case of 2026; the health department says there are no public exposure sites and is urging vaccination and monitoring for symptoms.

St. Louis County says a bat taken from a Kirkwood home on April 16 tested positive for rabies; no bites were reported. Officials urge caution and pet vaccinations.

Florida health officials have filed multiple complaints against Ponte Vedra dentist Francesco Sebastiani after patient deaths and alleged misleading advertising; a hearing could begin today.

Major insurers filed double‑digit Medigap increases this spring; Tampa Bay seniors are weighing alternatives as state filings are reviewed.

LDH confirmed Louisiana’s first measles case of 2026 in a Kenner child exposed during travel; shoppers at a Target and Walmart on Esplanade Ave. on Friday may have been exposed.

A new JAMA analysis finds suicide deaths among 15–34-year-olds fell about 11% after 988 launched, while New York and Connecticut report big rises in 988 contacts.

Dolly Parton Children’s Hospital will pause its developmental‑behavioral pediatrics clinic on June 29, 2026, prompting worry from families who rely on long‑wait specialty care.

Boston health officials say a traveler with measles passed through Logan Airport’s Terminal C on April 14; public‑health teams are tracing contacts and notifying possible exposures.

Lawmakers introduced the Maternal Health, Dignity and Consent Act to require informed consent before drug testing pregnant people and newborns, aiming to curb secret testing and reduce racial disparities.

West Side clinics report a climb in HIV diagnoses and later‑stage disease. Doctors point to long‑acting prevention and steady funding as critical fixes.

A new blood biomarker and a ‘p‑tau217’ clock could let doctors estimate when Alzheimer’s symptoms will begin, speeding diagnosis for symptomatic Twin Cities patients while raising important caveats.